Intensity Therapeutics Inc (NASDAQ: INTS) is -93.19% lower on its value in year-to-date trading and has touched a low of $0.26 and a high of $4.94 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INTS stock was last observed hovering at around $0.32 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.32, the stock is 3.02% and -10.49% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.08 million and changing 0.00% at the moment leaves the stock -81.99% off its SMA200. INTS registered -81.53% loss for a year compared to 6-month loss of -87.27%. The firm has a 50-day simple moving average (SMA 50) of $0.3631 and a 200-day simple moving average (SMA200) of $1.804425.
The stock witnessed a 10.62% gain in the last 1 month and extending the period to 3 months gives it a -63.89%, and is 0.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.85% over the week and 11.42% over the month.
Intensity Therapeutics Inc (INTS) has around 16 employees, a market worth around $8.47M and $0.00M in sales. Distance from 52-week low is 24.90% and -93.42% from its 52-week high. The company has generated returns on investments over the last 12 months (-3443.12%).
The EPS is expected to grow by 40.46% this year.
Intensity Therapeutics Inc (INTS) Top Institutional Holders
24.0 institutions hold shares in Intensity Therapeutics Inc (INTS), with institutional investors hold 13.25% of the company’s shares. The shares outstanding are 15.26M, and float is at 14.05M with Short Float at 2.76%. Institutions hold 10.08% of the Float.
The top institutional shareholder in the company is SAPIENT CAPITAL LLC with over 1.01 million shares valued at $4.95 million. The investor’s holdings represent 7.3712% of the INTS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 0.2 million shares valued at $1.0 million to account for 1.4948 of the shares outstanding. The other top investors are BROWN ADVISORY INC which holds 0.16 million shares representing 1.1488% and valued at over $0.77 million, while SIGMA PLANNING CORP holds 0.3491 of the shares totaling 47869.0 with a market value of $0.23 million.
Intensity Therapeutics Inc (INTS) Insider Activity
#####
